Thursday, March 9, 2023

CONFIRMATION OF SUBSCRIPTION - Option Advisor-3

Dear Trader,

Thank you for your recent subscription to Option Advisor-3! For more than 4 decades, Schaeffer's has remained one of the leading names in options, and we're excited to show you why!

Please take a few moments to look over your Subscriber Handbook, which will break down the specifics of your service, including trade type, frequency, trading philosophy, and more. The information found in this handbook will be an invaluable resource to your trading, and we encourage all subscribers to read their handbook thoroughly.

If you have any further questions after reading your handbook, please reach out to your Account Representative or our customer service department at 1-800-327-8833.

To view your handbook, open positions and trade history, click on the "My Account" button at the top of our homepage https://www.schaeffersresearch.com. Enter your username and password and hit the "Log In" button. Your service will be listed under the "My Products" section with a direct link to any open positions and trade history.

For easy access to your service, here are your username and password:

Your username is:  edwardlorilla1986.paxforex@blogger.com

Your password is:  *Xm6S?#+8vX4


Please be on the lookout for an additional email containing your Subscriber Quick Start Guide, and additional information regarding your Schaeffer's Account.

Click Here To View Your Account


To ensure you receive future correspondences from Schaeffer's, including critical trade alerts, we recommend that you add these 3 email addresses to your personal address book to ensure you receive all critical Schaeffer's communications:

1.  subscription@schaeffer.com

2.  service@sir-inc.com

3.  enews@schaeffer.com


In addition, if you opted into our Text Message Alert Service, you should have received your Welcome text by now. Please email service@sir-inc.com to resolve any issues with your enrollment.

If you have any questions along the way, please contact Schaeffer's CustomerService at 1-800-327-8833.


Happy trading!

The Schaeffer's Team 

 

DISCLAIMER

Schaeffer's Investment Research, Inc. (SIR) does not give individualized stock market advice. We publish information regarding companies in which we believe our subscribers may be interested and our reports reflect our sincere opinions. However, they are not intended to be personalized recommendations to buy, hold, or sell securities. Investments in the securities markets, and especially in options, are speculative and involve substantial risk. Only you can determine what level of risk is appropriate for you. Prior to buying or selling an option, an investor must have a copy of Characteristics and Risks of Standardized Options. You can access and download the booklet on The Options Clearing Corporation's (OCC) website at http://www.optionsclearing.com/about/publications/character-risks.jsp. This link reference is provided as a courtesy and does not imply that the OCC is endorsing SIR or its products. This booklet is also available for free from your broker or from any of the U.S. options exchanges. Due to the exclusive nature of our subscription services, your subscription fee is non-refundable.

We encourage you to invest carefully and to utilize the information available at the websites of the Securities and Exchange Commission at http://www.sec.gov and the Financial Industry Regulatory Authority at http://www.FINRA.org. You can review public companies' filings at the SEC's EDGAR page. The FINRA has published information on how to invest carefully at its website. We encourage you to get personal advice from your professional investment advisor or to make independent investigations before acting on information that we publish. Most of our information is derived directly from information published by the companies on which we report and/or from other sources we believe are reliable, without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action which you take in reliance on our statements.

Our personnel may own positions in the equities mentioned in our reports. However, all employees are prohibited from any transaction that directly or indirectly competes with the interests of our subscribers. We are not compensated in any way for publishing information about companies mentioned in our reports.

Testimonials may or may not be representative of actual results.


PERFORMANCE FIGURES

Performance figures are based on actual recommendations made by SIR. Due to the time critical nature of stock and options trading, brokerage fees, and the activity of other subscribers, SIR cannot guarantee that subscribers will mirror the exact performance stated on our track records or promotions. Performance numbers shown are based on trades subscribers could enter based on our tracking guidelines. Past results are not necessarily indicative of future performance.


LIMITATION ON SIR'S LIABILITY

SIR's liability, whether in contract, tort, negligence, or otherwise, shall be limited in the aggregate to direct and actual damages not to exceed the fees received by SIR from Subscriber. SIR will not be liable for consequential, incidental, punitive, special, exemplary or indirect damages resulting directly or indirectly from the use of or reliance upon any material provided by SIR. Without limitation, SIR shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscriber's inability to use or any delay in accessing SIR's website or any other source of material provided by SIR; (3) any absence of material on SIR's website; (4) SIR's failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material. SIR and Subscriber acknowledge that, without limitation, the above-enumerated conditions cannot be the probable result of any breach of any agreement between SIR and Subscriber.


DISCLAIMER OF WARRANTY

ANY AND ALL MATERIAL PROVIDED BY SIR IS PROVIDED "AS IS" AND SIR MAKES NO WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.


BROKERS

SIR is not affiliated with any brokerage firm and does not endorse or recommend any specific brokerage firm. SIR is not and will not be responsible for any trades made by a broker on the subscriber's behalf under any circumstances.


ACKNOWLEDGEMENT AND AGREEMENT

Notwithstanding any other agreement or other communications between SIR and Subscriber to the contrary, receipt or use of any material provided by SIR, at any time and through any means, whether directly or indirectly, represents acknowledgement by such person of this disclaimer and agreement with its terms and conditions.


COPYRIGHT NOTICE

SIR is the copyright owner of all information contained in this service, except as otherwise indicated. Other parties' trademarks and service marks that may be referred to herein are the property of their respective owners. You may print a copy of the information contained herein for your personal use only, but you may not reproduce or distribute the information to others or substantially copy the information on your own server, without prior written permission of SIR. You may link to SIR's website only if visitors are aware that it is SIR's website to which the link has been made. Use or reproduction of information from this service for any other purpose is expressly prohibited by law, and may result in civil and criminal penalties. Violators will be prosecuted to the maximum extent possible.


TELEPHONE CALL MONITORING AND RECORDS

Schaeffer's Investment Research, Inc. monitors and records all telephone calls made to or from its offices for quality control and training purposes.

Schaeffer's Investment Research, Inc.

5151 Pfeiffer Road – Suite 450

Cincinnati, OH 45242 – USA

1-800-448-2080

https://www.SchaeffersResearch.com

If you'd like to unsubscribe and stop receiving these emails click here .

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...